VivoSim gets Nasdaq delisting notice for bid price; proposes 1:5-1:20 reverse split

VivoSim Labs, INC.

Nasdaq notice on Aug 17, 2026: VIVS closing bid below $1 for 30 consecutive sessions.
Company has 180 days, to Feb 16, 2027, to regain $1+ bid for 10 straight days.
If not cured, may get 180-day extension if it meets other Nasdaq Capital Market standards.
Board proposes reverse stock split of 1-for-5 to 1-for-20, subject to stockholder approval at 2026 annual meeting.
Stock continues trading on Nasdaq as VIVS; delisting risk if compliance not regained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.